Coverart for item
The Resource Brain-disabling treatments in psychiatry : drugs, electroshock, and the psychopharmaceutical complex, Peter R. Breggin

Brain-disabling treatments in psychiatry : drugs, electroshock, and the psychopharmaceutical complex, Peter R. Breggin

Label
Brain-disabling treatments in psychiatry : drugs, electroshock, and the psychopharmaceutical complex
Title
Brain-disabling treatments in psychiatry
Title remainder
drugs, electroshock, and the psychopharmaceutical complex
Statement of responsibility
Peter R. Breggin
Creator
Contributor
Subject
Language
eng
Cataloging source
DNLM/DLC
http://library.link/vocab/creatorDate
1936-
http://library.link/vocab/creatorName
Breggin, Peter Roger
Index
index present
LC call number
RC483
LC item number
.B726 2008
Literary form
non fiction
Nature of contents
bibliography
NLM call number
WM 400
NLM item number
B833b 2008
http://library.link/vocab/relatedWorkOrContributorDate
1936-
http://library.link/vocab/relatedWorkOrContributorName
Breggin, Peter Roger
http://library.link/vocab/subjectName
  • United States
  • Psychotropic drugs
  • Brain
  • Electroconvulsive therapy
  • Iatrogenic diseases
  • United States
  • Mental Disorders
  • Brain Damage, Chronic
  • Drug Industry
  • Electroconvulsive Therapy
  • Psychotropic Drugs
  • United States
  • United States
Label
Brain-disabling treatments in psychiatry : drugs, electroshock, and the psychopharmaceutical complex, Peter R. Breggin
Instantiates
Publication
Note
Rev. ed. of: Electroshock : its brain-disabling effects / Peter Roger Bregin. c1979
Bibliography note
Includes bibliographical references (pages 463-526) and index
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
The brain-disabling, spellbinding effects of psychiatric drugs -- Deactivation syndrome (chemical lobotomy) caused by neuroleptics -- Neuroleptic-induced anguish, including agitation, despair, and depression -- Severe and potentially irreversible neurological syndromes (tardive dyskinesia and neuroleptic malignant syndrome) caused by neuroleptics -- Neuroleptic-induced neurotoxicity, brain damage, persistent cognitive deficits, dementia, and psychosis -- Recent developments in antidepressant label changes -- Antidepressant-induced mental, behavioral, and cerebral abnormalities -- Lithium and other drugs for bipolar disorder -- Electroconvulsive therapy (ECT) for depression -- From attention-deficit/hyperactivity disorder (ADHD) to bipolar disorder : diagnosing America's children -- Stimulant-induced brain damage, brain dysfunction, and psychiatric adverse reactions -- Antianxiety drugs, including behavioral abnormalities caused by Xanax and Halcion -- The Food and Drug Administration (FDA) and the National Institute of Mental Health (NIMH) : drug company advocates -- Drug company deceptions -- How to more safely stop taking psychiatric drugs -- Failed promises, last resorts, and psychotherapy
Control code
156863742
Dimensions
24 cm
Edition
2nd ed.
Extent
xxx, 546 pages
Isbn
9780826129345
Isbn Type
(alk. paper)
Lccn
2007029727
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
System control number
(OCoLC)156863742
Label
Brain-disabling treatments in psychiatry : drugs, electroshock, and the psychopharmaceutical complex, Peter R. Breggin
Publication
Note
Rev. ed. of: Electroshock : its brain-disabling effects / Peter Roger Bregin. c1979
Bibliography note
Includes bibliographical references (pages 463-526) and index
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
The brain-disabling, spellbinding effects of psychiatric drugs -- Deactivation syndrome (chemical lobotomy) caused by neuroleptics -- Neuroleptic-induced anguish, including agitation, despair, and depression -- Severe and potentially irreversible neurological syndromes (tardive dyskinesia and neuroleptic malignant syndrome) caused by neuroleptics -- Neuroleptic-induced neurotoxicity, brain damage, persistent cognitive deficits, dementia, and psychosis -- Recent developments in antidepressant label changes -- Antidepressant-induced mental, behavioral, and cerebral abnormalities -- Lithium and other drugs for bipolar disorder -- Electroconvulsive therapy (ECT) for depression -- From attention-deficit/hyperactivity disorder (ADHD) to bipolar disorder : diagnosing America's children -- Stimulant-induced brain damage, brain dysfunction, and psychiatric adverse reactions -- Antianxiety drugs, including behavioral abnormalities caused by Xanax and Halcion -- The Food and Drug Administration (FDA) and the National Institute of Mental Health (NIMH) : drug company advocates -- Drug company deceptions -- How to more safely stop taking psychiatric drugs -- Failed promises, last resorts, and psychotherapy
Control code
156863742
Dimensions
24 cm
Edition
2nd ed.
Extent
xxx, 546 pages
Isbn
9780826129345
Isbn Type
(alk. paper)
Lccn
2007029727
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
System control number
(OCoLC)156863742

Library Locations

    • Thomas Jefferson LibraryBorrow it
      1 University Blvd, St. Louis, MO, 63121, US
      38.710138 -90.311107
Processing Feedback ...